Abstract
Abstract. Despite the favorable prognosis for most patients with papillary thyroid cancer (PTC) there are problems of timely prediction of aggressive subtypes, metastasis, radioiodine resistance (RIR) of PTC, differentiation of indolent from aggressive forms of microcarcinomas, since the treatment tactics depend on this. This report considers a new direction in the development of clinical thyroidology – cytological prediction of aggression and RIR of PTC.
The aim was to analyze the literature data and present the results of our own studies on the determination of cytological manifestations of aggression and RIR of PTC, which will allow us to develop effective methods for early preoperative prediction of tumor aggression, which will help determine adequate treatment tactics.
Material and methods. A review of literature sources was conducted, and the data of our own studies were analyzed. Methods of cytological and immunocytochemical examinations of PTC and their metastases smears obtained as a result of fine-needle aspiration biopsy (FNAB) were used.
Results. Literature data indicate that the latest approach in thyroidology is the determination of certain cytological features (adhesive properties of cells, architecture of cell layers, nuclear-cytoplasmic ratio, presence of atypical histiocytoid cells, multinucleated cells of the foreign body type) as prognostic factors. We have conducted for the first time a comprehensive cytological and immunocytochemical studies of PTC and their metastases punctates of patients with the development of aggression and RIR compared to patients with a positive effect of radioiodine therapy (RIT). This allowed us to propose a decrease in the expression of thyroid peroxidase (TPO), high expression of cytokeratin 17 (CK17) and the emergence of special cellular phenotypes as cytological markers for predicting aggression and RIR of PTC.
Conclusions. The results of the analysis of literary data and our own studies demonstrate fundamentally new possibilities for using the method of cytological examination of the FNAB material for PTC.
References
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.
Pyo JS, Sohn JH, Chang K. Prognostic role of metastatic lymph node ratio in papillary thyroid carcinoma. J Pathol Transl Med. 2018 Sep;52(5):331-8. doi: 10.4132/jptm.2018.08.07.
Liu FH, Kuo SF, Hsueh C, Chao TC, Lin JD. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis. J Surg Oncol. 2015 Aug;112(2):149-54. doi: 10.1002/jso.23967.
Sitges-Serra A, Lorente L, Mateu G, Sancho JJ. Therapy of endocrine disease: Central neck dissection: a step forward in the treatment of papillary thyroid cancer. Eur J Endocrinol. 2015 Dec;173(6):R199-206. doi: 10.1530/EJE-15-0481.
Zhao H, Li H. Meta-analysis of ultrasound for cervical lymph nodes in papillary thyroid cancer: Diagnosis of central and lateral compartment nodal metastases. Eur J Radiol. 2019 Mar;112:14-21. doi: 10.1016/j.ejrad.2019.01.006.
Lee YJ, Kim DW, Park HK, Kim DH, Jung SJ, Oh M, et al. Preoperative ultrasound diagnosis of nodal metastasis in papillary thyroid carcinoma patients according to nodal compartment. Ultrasound Med Biol. 2015 May;41(5):1294-300. doi: 10.1016/j. ultrasmedbio.2015.01.003.
Cai YF, Wang QX, Ni CJ, Guo GL, Li Q, Wang OC, et al. The clinical relevance of psammoma body and Hashimoto thyroiditis in papillary thyroid carcinoma: a large case-control study. Medicine (Baltimore). 2015 Nov;94(44):e1881. doi: 10.1097/MD.0000000000001881.
Kim Y, Kim MH, Jeon S, Kim J, Kim C, Bae JS, et al. Prognostic implication of histological features associated with EHD2 expression in papillary thyroid carcinoma. PLoS One. 2017 Mar 30;12(3):e0174737. doi: 10.1371/journal.pone.0174737.
Tumors of the thyroid gland. In: Lloyd RV, Osamura RY, Kloppel G, Rosai J, eds. WHO classifications of tumours of the endocrine organs. 4th ed. Geneva, Switzerland: World Health Organization; 2017.
Roman S, Sosa JA. Aggressive variants of papillary thyroid cancer. Curr Opin Oncol. 2013 Jan;25(1):33-8. doi: 10.1097/ CCO.0b013e32835b7c6b.
